Precipio
In Brief This Week: Thermo Fisher Scientific, DNAnexus, Precipio, Delfi Diagnostics, Streck, More
News items for the week of Sept. 12, 2022.
Fisher Healthcare to Distribute Precipio HemeScreen Assays
The agreement allows Precipio to expand its distribution through Fisher's sales channels rather than build its own sales force.
Precipio Receives CE-IVD Mark for Hematologic Cancer Panels
The company said it can now market its HemeScreen MPN, AML, Anemia/MDS, and CLL panels in the European Union and the UK.
Former Precipio CFO, Son Agree to Settle SEC Insider Trading Lawsuit
Former Precipio CFO Carl Iberger was charged with providing confidential information regarding a company distribution deal for a COVID-19 test.
Apr 26, 2019
Precipio to Effect 1-for-15 Reverse Stock Split
Mar 13, 2018
Precipio Settles Lawsuit With Investment Group
Feb 27, 2018
Precipio Sued Over Transgenomic Securities Agreement
Nov 13, 2017
Precipio Completes Public Offering, Raises $2.7M
Apr 17, 2017
Transgenomic Closes Bridge Financing
Feb 21, 2017
Transgenomic Delisted from Nasdaq
Jan 12, 2017